Dexmedetomidine: A safe alternative to general anesthesia for endovascular stroke treatment

Journal of NeuroInterventional Surgery

Volumn 6, Issue 4, 2014, Pages 270-275

  Whalin, Matthew K ^a   Lopian, Susan ^a,b   Wyatt, Katleen ^b   Sun, Chung Huan J ^a   Nogueira, Raul G ^a,b   Glenn, Brenda A ^b   Gershon, Raphael Y ^a   Gupta, Rishi ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRADY MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; DEXMEDETOMIDINE; HYPERTENSIVE FACTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; HYPNOTIC SEDATIVE AGENT;

AGED; ARTICLE; ASPIRATION PNEUMONIA; BLEEDING; BLOOD PRESSURE; BRADYCARDIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SAFETY; ENDOVASCULAR STROKE; ENDOVASCULAR SURGERY; FEMALE; GENERAL ANESTHESIA; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PNEUMONIA; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; SEDATION; SYSTOLIC BLOOD PRESSURE; THROMBUS ASPIRATION; TRACHEOSTOMY; COMPARATIVE STUDY; DEEP SEDATION; DRUG EFFECTS; MIDDLE AGED; PROCEDURES; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME;

AGED; ANESTHESIA, GENERAL; BLOOD PRESSURE; DEEP SEDATION; DEXMEDETOMIDINE; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME;

EID: 84899641463     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2013-010773     Document Type: Article

References (19)

1. Davis MJ, Menon BK, Baghirzada LB, et al. Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology 2012;116:396-405.
2. Abou-Chebl A, Lin R, Hussain MS, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke 2010;41:1175-9.
3. Jumaa MA, Zhang F, Ruiz-Ares G, et al. Comparison of safety and clinical and radiographic outcomes in endovascular acute stroke therapy for proximal middle cerebral artery occlusion with intubation and general anesthesia versus the nonintubated state. Stroke 2010;41:1180-4.
4. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007;298:2644-53. (Pubitemid 350254956)
5. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009;301:489-99.
6. Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003;17:576-84. (Pubitemid 37296621)
7. Mack PF, Perrine K, Kobylarz E, et al. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol 2004;16:20-5. (Pubitemid 38057394)
8. Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-4. (Pubitemid 30248478)
9. Higashida R, Furlan A, Roberts H, et al. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol 2003;14:S493-4.
10. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
11. Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001;32:1330-5. (Pubitemid 32530418)
12. Farag E, Argalious M, Sessler DI, et al. Use of alpha(2)-agonists in neuroanesthesia: an overview. Ochsner J 2011;11:57-69.
13. Drummond JC, Dao AV, Roth DM, et al. Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology 2008;108:225-32. (Pubitemid 351156732)
14. Drummond JC, Sturaitis MK. Brain tissue oxygenation during dexmedetomidine administration in surgical patients with neurovascular injuries. J Neurosurg Anesthesiol 2010;22:336-41.
15. Rozet I, Muangman S, Vavilala MS, et al. Clinical experience with dexmedetomidine for implantation of deep brain stimulators in Parkinson's disease. Anesth Analg 2006;103:1224-8. (Pubitemid 44627349)
16. Mason KP, Zurakowski D, Zgleszewski SE, et al. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 2008;18:403-11. (Pubitemid 351490487)
17. Leonardi-Bee J, Bath PM, Phillips SJ, et al. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315-20. (Pubitemid 34517053)
18. Ahmed N, Wahlgren N, Brainin M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke 2009;40:2442-9.
19. Potter JF, Robinson TG, Ford GA, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 2009;8:48-56.